<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Pathology 2.0 – Nine Years Later	</title>
	<atom:link href="https://tissuepathology.com/2018/06/20/pathology-2-0-nine-years-later/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com/2018/06/20/pathology-2-0-nine-years-later/</link>
	<description>Educational and informative</description>
	<lastBuildDate>Thu, 21 Jun 2018 16:53:48 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>
		By: Jared N Schwartz		</title>
		<link>https://tissuepathology.com/2018/06/20/pathology-2-0-nine-years-later/#comment-158402</link>

		<dc:creator><![CDATA[Jared N Schwartz]]></dc:creator>
		<pubDate>Thu, 21 Jun 2018 16:53:48 +0000</pubDate>
		<guid isPermaLink="false">http://tissuepathology.com/?p=13905#comment-158402</guid>

					<description><![CDATA[Keith thanks for remembering Futurescape and Dr Kass’s amazing  force and willpower to get it off the ground. The specific purpose was to have a forum where CAP could bring together pathologists 
from all practice settings to learn about new medical technologies 
that would soon or were already ready for clinical 
use. New diagnostics, impact of digitization, new optical imaging and image analysis methods (in vitro and in vivo), increasing new powerful methods in proteomics, genomics (NGS), etc. 
The speakers were carefully selected (not sure how you slipped in🤔) from many areas of medicine and industry. The one common 
criteria were all these new technologies would in our opinion have major impacts on Pathology (including pathologists providing more
direction on drug development and use), improving diagnostic sensitivity and specificity and would ultimately impact every aspect of Pathology. The PRIMARY purpose of conference was to “ cry out” that if Pathology Leadership (ABP/APC/ Professional Society’s and others did not act NOW “2007” these Pathology tools of “future”would be lost to Pathology and adopted by others. It is now 2018. Many leaders (sadly not near enough) did heed the call and now many of above are considered part of Pathology, however not enough has changed particularly as regarding the intense training required to ensure our residents and fellows are prepared to go into practice and integrate these technologies into the everyday practice of pathology. Other Specialties already have or are moving much faster to incorporate many of above technologies into their Board Certification requirements and thus their training programs are working hard to adequately prepare their residents for use of these tools themselves as they move into active practice. 
I optimistically “believe”not too late for Pathology but without aggressive action by ABP/APC and others our Specialty in danger of being viewed as technicians rather than physicians by House of 
Medicine and Healthcare Policy Makers. Our trainees need mentors 
to guide and encourage them. Where are they? Again Thanks 
Keith for remembering FutureScape and also reminding us that much remains to be done.]]></description>
			<content:encoded><![CDATA[<p>Keith thanks for remembering Futurescape and Dr Kass’s amazing  force and willpower to get it off the ground. The specific purpose was to have a forum where CAP could bring together pathologists<br />
from all practice settings to learn about new medical technologies<br />
that would soon or were already ready for clinical<br />
use. New diagnostics, impact of digitization, new optical imaging and image analysis methods (in vitro and in vivo), increasing new powerful methods in proteomics, genomics (NGS), etc.<br />
The speakers were carefully selected (not sure how you slipped in🤔) from many areas of medicine and industry. The one common<br />
criteria were all these new technologies would in our opinion have major impacts on Pathology (including pathologists providing more<br />
direction on drug development and use), improving diagnostic sensitivity and specificity and would ultimately impact every aspect of Pathology. The PRIMARY purpose of conference was to “ cry out” that if Pathology Leadership (ABP/APC/ Professional Society’s and others did not act NOW “2007” these Pathology tools of “future”would be lost to Pathology and adopted by others. It is now 2018. Many leaders (sadly not near enough) did heed the call and now many of above are considered part of Pathology, however not enough has changed particularly as regarding the intense training required to ensure our residents and fellows are prepared to go into practice and integrate these technologies into the everyday practice of pathology. Other Specialties already have or are moving much faster to incorporate many of above technologies into their Board Certification requirements and thus their training programs are working hard to adequately prepare their residents for use of these tools themselves as they move into active practice.<br />
I optimistically “believe”not too late for Pathology but without aggressive action by ABP/APC and others our Specialty in danger of being viewed as technicians rather than physicians by House of<br />
Medicine and Healthcare Policy Makers. Our trainees need mentors<br />
to guide and encourage them. Where are they? Again Thanks<br />
Keith for remembering FutureScape and also reminding us that much remains to be done.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Eric Glassy, MD		</title>
		<link>https://tissuepathology.com/2018/06/20/pathology-2-0-nine-years-later/#comment-158389</link>

		<dc:creator><![CDATA[Eric Glassy, MD]]></dc:creator>
		<pubDate>Thu, 21 Jun 2018 04:16:53 +0000</pubDate>
		<guid isPermaLink="false">http://tissuepathology.com/?p=13905#comment-158389</guid>

					<description><![CDATA[Keith

Yes!
Let&#039;s bring back Futurescape. 
Pathology 3.0 with Machine Learning, Artificial Intelligence, Big Data and Computational Pathology.
Thanks for reminding us of how good FutureScape was. 
Eric]]></description>
			<content:encoded><![CDATA[<p>Keith</p>
<p>Yes!<br />
Let&#8217;s bring back Futurescape.<br />
Pathology 3.0 with Machine Learning, Artificial Intelligence, Big Data and Computational Pathology.<br />
Thanks for reminding us of how good FutureScape was.<br />
Eric</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
